Results 101 to 110 of about 2,521,110 (208)

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). [PDF]

, 2016
1-Propionyl-d-lysergic acid diethylamide hemitartrate (1P-LSD) has become available as a 'research chemical' in the form of blotters and powdered material.
Folker Westphal, Alexander Stratford, Simon D. Brandt, Kavanagh, PV, Simon P. Elliott, Halberstadt, AL, Elliott, SP, Jason Wallach, Hoang, K, Stratford, A, Brandt, SD, Westphal, F, Wallach, J, Khoa Hoang, Adam L. Halberstadt, Pierce V. Kavanagh   +15 more
core   +1 more source

A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder

Brain Sciences
Objective: This study aims to provide an overview of pharmacological trials that examine the neurocognitive effects of psychedelics among healthy individuals and patients with post-traumatic stress disorder (PTSD) or major depressive disorder (MDD ...
Mario Renato Velit-Salazar, Paulo R. Shiroma, Eloise Cherian   +2 more
doaj   +1 more source

Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans [PDF]

, 2021
Background: The pharmacokinetics of oral lysergic acid diethylamide are unknown despite its common recreational use and renewed interest in its use in psychiatric research and practice.
Dolder, Patrick C., Rentsch, Katharina M., Liechti, Matthias E., Schmid, Yasmin, Haschke, Manuel   +4 more
core  

Sex-dependent effects of psychedelics: review of evidence from rodent models

Frontiers in Psychiatry
Classic psychedelics, including psilocybin, LSD, DMT, 5-MeO-DMT, mescaline, and phenethylamines such as DOI, exert their core effects through 5-HT2A receptor agonism, inducing widespread neurobiological and behavioral changes relevant to psychiatric ...
Rafał Marecki, Wiktoria Zaniewska, Adam Hamed, Napoleon Waszkiewicz, Jacob J. Baker, Kacper Łukasiewicz, Kacper Łukasiewicz, Kacper Łukasiewicz   +7 more
doaj   +1 more source

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD) [PDF]

, 2019
The psychedelic properties of lysergic acid diethylamide (LSD) have captured the imagination of researchers for many years and its rediscovery as an important research tool is evidenced by its clinical use within neuroscientific and therapeutic settings.
Folker Westphal, Alexander Stratford, Simon D. Brandt, Kavanagh, PV, Simon P. Elliott, Halberstadt, AL, Elliott, SP, Jason Wallach, Stratford, A, Brandt, SD, Westphal, F, Dowling, G, Wallach, J, Geraldine Dowling, Adam L. Halberstadt, Pierce V. Kavanagh   +15 more
core   +1 more source

sj-docx-1-jop-10.1177_02698811211055855 – Supplemental material for Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study

, 2022
Supplemental material, sj-docx-1-jop-10.1177_02698811211055855 for Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative ...
David Luke (11301588), Peter S Hendricks (9387032), Heith Copes (9387020), Luke TJ Williams (12211851), Shlomi Raz (12211860), Neiloufar Family (12211848)   +5 more
core   +1 more source

Psychedelics as a potential treatment for tobacco use disorder: a systematic review

Discover Mental Health
Introduction Despite considerable efforts, tobacco use disorder persists as a significant public health issue. The effectiveness of current smoking cessation therapies is limited, leading to a growing interest in alternative treatment approaches such as ...
S. K. Spoelstra, R. A. Schoevers, S. D. Venema, H. Knegtering   +3 more
doaj   +1 more source

Treatment of neuropathic pain with repeated low-dose MDMA: a case report

Frontiers in Psychiatry
A 64-year-old male patient who suffered from traumatic life experiences and neuropathic pain after oncological chemotherapy was treated with medium to high doses of lysergic acid diethylamide (LSD) and high doses and microdoses of ...
Peter Gasser, Matthias E. Liechti, Friederike Holze   +2 more
doaj   +1 more source

Therapeutic Use of Lysergic Acid Diethylamide and Psilocybin [PDF]

openLa tesi ha come scopo quello di fare una panoramica sul possibile utilizzo in ambito terapeutico della dietilamide dell'acido lisergico e della psilocibina.
ROSELLI, PIETRO
core  

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects [PDF]

, 2017
Background and Objective: Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. The aim of the present study was to characterize the pharmacokinetics and exposure–response relationship of oral LSD.
Katharina M. Rentsch, Dolder, Patrick C, Liechti, Matthias E, Steuer, Andrea E, Rentsch, Katharina M, Schmid, Yasmin, Andrea E. Steuer, Thomas Kraemer, Dolder, Patrick C., Yasmin Schmid, Matthias E. Liechti, Steuer, Andrea E., Patrick C. Dolder, Rentsch, Katharina M., Liechti, Matthias E., Felix Hammann, Kraemer, Thomas, Hammann, Felix   +17 more
core   +2 more sources